System Transmission

Top Signal

100#1 JOB

Activity

2191Ripe

+949 today

System

Livenow

Terminal Asset View

stockNASDAQ

MIRM

$90.66+0.98%

Mirum Pharmaceuticals Inc

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

32Neutral

Live Analysis Active

Company Mission

Mirum Pharmaceuticals develops and sells medicines specifically for rare liver diseases that affect both children and adults. Their drugs are prescribed by doctors and used by patients who have limited treatment options for these serious conditions. The company makes money primarily by selling these medications to healthcare providers, hospitals, and pharmacies, with revenue coming from drug sales and potential partnerships.

MIR

Industry Context

The biotech industry focuses on developing new medicines and treatments, often for rare or difficult-to-treat conditions. Companies in this space typically invest heavily in research and development, with their stock prices often reacting strongly to news about drug approvals, clinical trial results, or regulatory decisions.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

33Matrix

Market Momentum

44.7— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.6x— Normal Volume

Today's Change

0.98%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing MIRM across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 07:20 AM UTC

As-of 03-15-2026 07:05 UTC

Develops medicines for rare liver diseases and makes money by selling these treatments through hospitals and pharmacies.

Price below key moving averages suggests caution as the stock may be in a downtrend pattern, which indicates potential movement.

Biotech sector faces volatility as regulatory approvals and clinical trial results drive investor sentiment, suggesting investor sentiment.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...